This 2022 study evaluated the impact of combining alkalization therapy and intravenous vitamin C (IVC) with chemotherapy in patients with small-cell lung cancer (SCLC). The combination therapy aimed to neutralize the acidic tumor microenvironment and enhance the cytotoxic effects of chemotherapy. Results indicated that patients receiving the combined treatment exhibited
